UPDATE - FEBRUARY 20, 2018: Despite bold outcry from disability and civil rights groups, HR 620 has passed in the House. PPMD has been in touch with Senate leadership and the path in the Senate is uncertain, but we urge our community to…
Added by Annie Kennedy on February 12, 2018 at 9:30am — No Comments
Care for the heart has long been a priority for PPMD. Over the past several years, PPMD’s Cardiac Initiative has given rise to:
Added by Kathi Kinnett on February 7, 2018 at 1:31pm — No Comments
Today Santhera announced that they have received a negative opinion on the Appeal for Authorization of Raxone®…Continue
Added by PPMD on January 26, 2018 at 10:00am — No Comments
Today, Summit announced positive 24-week interim data from PhaseOut DMD, their Phase 2 clinical trial of the utrophin modulator ezutromid.…Continue
Added by PPMD on January 25, 2018 at 10:00am — No Comments
PPMD is thrilled to announce that after many years in development, the Centers for Disease Control (CDC) has published updated Care Considerations for Duchenne in The Lancet…Continue
Added by Kathi Kinnett on January 24, 2018 at 10:30am — No Comments
The PPMD Advocacy Conference registration is live! Join us March 4-6 in Washington DC to advocate for Duchenne…Continue
Added by Ryan Fischer on January 23, 2018 at 4:50pm — No Comments
In January of 2014 we held our inaugural PAAC Leadership Workshop in Washington,DC. The day included engagement with federal policy makers, congressional staff, and research leaders. At the end of the day, a long-time colleague of mine from the FDA who had spent the entire day with us pulled me aside…Continue
(Photo used with permission from family.)
“DMD gene therapy went well. It was started at 1:15 PM and ended at 2:27 PM”
On Thursday, January 4, I received this message from Dr. Jerry Mendell accompanied by the photo above – Dr. Mendell at…
Remember that hot June day in 2015 when hundreds of Duchenne community members rallied together at the U.S. Capitol for PPMD’s EndDuchenne rally? That same day, our longtime Congressional champions Senators Roger Wicker (R-MS) and Amy Klobuchar (D-MN) introduced the Patient Focused Impact…Continue
Added by Annie Kennedy on January 9, 2018 at 3:30pm — No Comments
PPMD's Certified Duchenne Care Center (CDCC) Program was developed to make comprehensive Duchenne care and services, provided in agreement with the…Continue
Added by Kathi Kinnett on January 8, 2018 at 4:30pm — No Comments
When our children are hurting, we go to our medicine cabinets and take great care to select products that will ease their pain. Reduce the fever. Relieve the ache.
In Duchenne, we know that the products and supplements prescribed often come with side effects. But we carefully weigh…
Added by Pat Furlong on January 3, 2018 at 12:00pm — No Comments
Parent Project Muscular Dystrophy believes in the promise that gene therapy holds for the Duchenne community. And so we set an ambitious fundraising goal for our Gene Therapy Initiative. In fact, $500,000 is our largest fundraising goal ever.
Added by PPMD on January 3, 2018 at 9:30am — No Comments
I am a 22 year old living with Duchenne, and opportunities for clinical trial participation are few and far between. It is one of the frustrating realities of my diagnosis and my age. Although it has never swayed my commitment to this community, I have to be honest. It can be discouraging at…
Added by PPMD on December 30, 2017 at 10:03am — No Comments
I have some exciting news: Your response to Sean and Mindy Rice’s generous matching gift of $200,000 has been incredibly inspiring to the Parent Project Muscular Dystrophy board. You’ve shown us that PPMD’s Gene Therapy Initiative matters to you, and we want to keep up the momentum.…
Added by PPMD on December 26, 2017 at 3:00pm — No Comments
My son Bazi is four years old and has Duchenne muscular dystrophy. It's been over a year now, and this sentence is still extraordinarily hard for me to write.
When we got the diagnosis, my emotions shifted between paralyzing fear, incredible…Continue
Added by PPMD on December 22, 2017 at 11:30am — No Comments
Viral gastrointestinal (GI) viruses are no fun for anyone, but they are especially worrisome for a person living with Duchenne muscular dystrophy. GI viruses affect the GI track – the stomach and intestine (i.e., ‘gut’) – resulting in abdominal pain/discomfort, nausea, vomiting, intestinal…Continue
Added by Kathi Kinnett on December 21, 2017 at 10:30am — No Comments
For the last many months, we have all been watching gene therapy make headlines around the world, across various diseases. As you know, earlier this year PPMD launched a Gene Therapy Initiative to help support the exploration of various gene therapy technologies in…Continue
When our son, Jonathan, was diagnosed with Duchenne, we didn’t know where our family would find the strength to fight. But the PPMD community has always shown us that we are never alone in our fight to end Duchenne.
Added by PPMD on December 19, 2017 at 2:56pm — No Comments
With advancements made in Duchenne gene therapies now coming to fruition, a number of questions are being asked about who may qualify for the upcoming trials.
While the inclusion criteria of each trial will be different based on age, mutation (in some…Continue
PTC Therapeutics provided a brief update on the Formal Dispute Resolution Request process for ataluren.
Read the update from PTC:
As we enter the holiday season, I wanted to thank the…
Added by PPMD on December 13, 2017 at 11:00am — No Comments